Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
Dr. Hilde Vanaken, Head Industry Leaders, Life Sciences & Healthcare
You have these already downloaded
We have sent you a copy of the report to your email again.
Know how digital technologies can disrupt medication management and achieve patient centricity in clinical trials.
Watch experts highlight the challenges associated with traditional medication and providing practical approaches to overcome them.
Administration of medication plays a vital role in the efficiency and efficacy of clinical trials. However, there have been many challenges encountered in this regard, including incorrect medication intake, complex and incomplete medication instructions, limited real-time insights into at-home intake, manual and error-prone medication management, limited personalized and preventive support, and high supply waste. Smart medications are equipped with approaches to address these challenges, as they provide personalized notifications enabled with smart questionnaires, voice and multimedia options, and behavioral insights enabling smart-site assistance.
Automating Third Party Data Transfer Through Digitized Electronic DTA
TCS ADD™ Risk-Based Quality Management Platform
Reimagining Reporting and Visualization During CDM
Advancing Regulatory Intelligence with Conversational, Generative AI
Learn how we can help you bring drugs to the market faster.
Talk to our experts